The largest database of trusted experimental protocols

2 protocols using hy 10355

1

Murine Macrophage Culture and Stimulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The mouse peritoneal macrophages (MPMs) extracted from C57BL/6 female mice and MH-S cells and were cultured routinely in Roswell Park Memorial Institute (RPMI) medium (HyClone) supplemented with 10% fetal bovine serum (FBS), l-glutamine, and penicillin. Immortalized bone marrow-derived macrophage (iBMDM) cells and Raw264.7 cells were cultured routinely in Dulbecco’s modified Eagle’s medium (DMEM) (HyClone) supplemented with 10% FBS, l-glutamine, and penicillin. All cells were cultured in antibiotic-free medium before PA stimulation or inhibitor pretreatment. The cells were pretreated with VX-765 (HY-13205, Med Chem Express), Nig (HY-13205, Med Chem Express), IL-1β (HY-P7073, Med Chem Express), IL-1β receptor inhibitor (TLR-1, HY-W011400, Med Chem Express), AKT inhibitor VIII (HY-10355, Med Chem Express), or IFN-β (CAT 300-02BC, PeproTech) for the indicated times before stimulation with PA, as indicated; multiplicity of infection (MOI) values are given for the different times.
+ Open protocol
+ Expand
2

Cell Line Maintenance and Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human HCC cell lines (Huh7, HepG2) were obtained from the cell bank of the Type Culture Collection of the Chinese Academy of Sciences. HEK-293T and HCC cell lines (SM-386, YY-8103, MHCC97-H) were obtained from ATCC cell bank, and routinely maintained in Dulbecco’s modified Eagle’s medium (DMEM, Gibco) supplemented with 10% fetal bovine serum (FBS, Gibco). L02 cells were purchased from Shanghai Zhong Qiao Xin Zhou Biotechnology Co. Ltd., and cultured in Roswell Park Memorial Institute (RPMI) 1640 medium (Gibco) supplemented with 10% FBS. All cells were maintained in a humidified 5% CO2 atmosphere at 37 °C, and tested for mycoplasma contamination every month. FCN3-overexpressed MHCC97-H, YY-8103 and control cells were treated with T0901317 (HY-10626, MedChemExpress), Erastin (HY-15736, MedChemExpress), FINO2 (HY-129457, MedChemExpress), AKTi-1/2 (HY-10355, MedChemExpress), Ferrostatin-1 (SML0583, Sigma-Aldrich), N-acetyl-L-cysteine (A9165, Sigma-Aldrich), Z-VAD-fmk (FMK001, R&D Systems), and Necrostatin-1 (HY-15760, MedChemExpress) for indicated time.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!